Isoegomaketone
Isoegomaketone is an orally active apoptosis inducer and radiosensitizer. Isoegomaketone regulates multiple key signaling pathways such as PI3K/AKT/mTOR, NF-κB, MAPK, cleaves Caspase family proteins and PARP, and modulates Bax, AIF and endoplasmic reticulum stress proteins. Isoegomaketone also induces autophagy and keratinocyte proliferation, effectively reduces the levels of inflammatory factors and oxidative stress, inhibits adipocyte differentiation, and resensitizes TRAIL-resistant cancer cells. Isoegomaketone can be applied to research related to colorectal cancer, melanoma, lung cancer, prostate cancer, liver cancer, as well as rheumatoid arthritis and obesity.
For research use only. We do not sell to patients.
- CAS No.: 34348-59-9
- Formula: C10H12O2
- Molecular Weight:164.20
-
Storage:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
All Caspase Isoforms
More
Biological Activity
Description
In Vitro
Isoegomaketone (10-100 μM) potently induces apoptosis in human colorectal adenocarcinoma DLD1 cells via the mitochondria-dependent cytochrome c and AIF pathways, with an IC50 of approximately 25 μM[1].
Isoegomaketone (10 μM; 24 h) significantly promotes the proliferation and migration of human keratinocyte HaCaT cells by activating the MAPK/ERK pathway[1].
Isoegomaketone (25-50 μM; 24 h) induces the translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus in human colon cancer DLD1 cells[2].
Combination treatment with Isoegomaketone (100 µg/mL) and 8 Gy radiotherapy significantly reduces the expression of HIF-1α and the phosphorylation levels of PI3K and AKT in HT-29 colon cancer cells, compared with monotherapy[3].
Combination treatment with Isoegomaketone (100 µg/mL) and 8 Gy radiotherapy significantly enhances apoptosis (via upregulating BAX expression and downregulating BCL-2 expression) and autophagy (via upregulating Beclin-1 expression and promoting the conversion of LC3 I to LC3 II) in HT-29 colon cancer cells, compared with monotherapy[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human colon cancer DLD1 cells
-
Concentration:10 μM, 25 μM, 50 μM, 100 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in ~20% of DLD1 cells at 50 μM.
Induced apoptosis in ~70% of DLD1 cells at 100 μM.
Triggered cleavage of PARP, producing the characteristic 85 kDa cleaved fragment alongside the full-length 116 kDa protein at 50 μM.
-
Cell Line:human colon cancer DLD1 cells
-
Concentration:25 μM, 50 μM
-
Incubation Time:24 h
-
Result:Caused dose-dependent release of cytochrome c from mitochondria to cytosol, with reduced mitochondrial cytochrome c levels and increased cytosolic cytochrome c levels at 25 μM and 50 μM.
Induced dose-dependent Bid cleavage, shown by reduced full-length Bid levels at 25 μM and 50 μM.
Promoted Bax translocation from cytosol to mitochondria, shown by reduced cytosolic Bax levels and increased mitochondrial Bax levels at 25 μM and 50 μM.\nInduced dose-dependent translocation of AIF, with decreased AIF levels in mitochondrial fractions, transiently increased levels in cytosolic fractions, and increased levels in nuclear fractions at 25 μM and 50 μM.
In Vivo
Isoegomaketone (10 mg/kg; p.o.; once daily; for 7 consecutive days) significantly reduces arthritis severity, hind paw inflammatory responses, ankle joint pathological damage, and NLR levels in collagen antibody-induced rheumatoid arthritis BALB/c mice[1].
Isoegomaketone (10 mg/kg; daily) significantly reduces body weight gain and visceral fat accumulation by 45% in high-fat diet-induced obese C57BL/6J mice[1].
Combination of Isoegomaketone (100 mg/kg; i.p.; once daily; for 14 consecutive days) with daily 8 Gy radiotherapy achieves complete tumor eradication and 100% survival rate in HT-29 colon cancer xenograft mice, while alleviating radiotherapy-induced intestinal injury by regulating cell apoptosis, autophagy and the PI3K/AKT/mTOR signaling pathway[3].
Isoegomaketone (5-10 mg/kg/day; oral administration; once daily; for 4 consecutive days) dose-dependently alleviates collagen antibody-induced rheumatoid arthritis in male BALB/c mice[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude (male, 4 weeks-old, weight 18~22 g, HT-29 human colon cancer cells xenograft)[3]
-
Dosage:100 mg/kg; 8 Gy (daily X-ray radiotherapy)
-
Administration:i.p.; daily; 14 days
-
Result:Achieved almost complete elimination of xenograft tumors with no recurrence observed over the treatment period.
Resulted in a 100% mouse survival rate over 14 days, compared to 40-60% survival with either monotherapy and 0% survival in controls.
Significantly upregulated BAX expression and downregulated BCL-2 expression in tumor tissue.
Enhanced the conversion of LC3 I to LC3 II and upregulated Beclin-1 expression to a greater extent than monotherapy.
Increased peripheral blood levels of white blood cells, neutrophils, and monocytes compared to monotherapy or control groups.
Reduced radiation-induced malondialdehyde levels in intestinal tissue.
Increased glutathione and catalase activities in intestinal tissue compared to radiotherapy alone.
Decreased levels of TNF-α, NF-κB, and IL-1β in intestinal tissue compared to radiotherapy alone.
Reversed radiotherapy-induced increases in γH2AX expression and phosphorylation of PI3K, AKT, and mTOR in intestinal tissue.
Improved histopathological damage to intestinal villi.
-
Animal Model:BALB/c (male, 5 weeks old, collagen antibody-induced arthritis model)[4]
-
Dosage:5 mg/kg/day; 10 mg/kg/day
-
Administration:p.o.; once daily; 4 days (days 3-6)
-
Result:Reduced arthritic score by 73%, paw volume by 15%, and paw thickness by 14% at day 7 (10 mg/kg/day dose).
Lowered neutrophil-to-lymphocyte ratio by 85% at day 7 (10 mg/kg/day dose).
Decreased mean histopathological arthritic score to 1.17 (10 mg/kg/day dose).
Significantly reduced paw volume by 9.5% (day 5), 17.4% (day 6), and 13.7% (day 7) (10 mg/kg/day dose).
Significantly reduced paw thickness by 15.8% (day 6) and 14.2% (day 7) (10 mg/kg/day dose).
Attenuated arthritic signs from days 5 through 7 and delayed disease onset compared to apigenin-treated controls (10 mg/kg/day dose).
Reduced synovial hyperplasia and inflammatory cell infiltration in joint spaces (10 mg/kg/day dose).
Resulted in mean histopathological arthritic score of 2.83 (5 mg/kg/day dose).
Showed no significant reductions in paw volume, paw thickness, arthritic score, or neutrophil-to-lymphocyte ratio compared to control CAIA mice (5 mg/kg/day dose).
Chemical Information
-
CAS No. 34348-59-9
-
Appearance Liquid (Density: 1.003±0.06 g/cm3)
-
Molecular Weight 164.20
-
Formula C10H12O2
-
Color Colorless to light yellow
-
SMILES
CC(C)/C=C/C(C1=COC=C1)=O
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
3T3-L1 preadipocyte-to-adipocyte differentiation
3T3-L1 preadipocytes are induced to differentiate after growth arrest using adipogenic media containing insulin, dexamethasone, and IBMX; differentiation is assessed by lipid-droplet accumulation, triglyceride increase, Oil Red O staining, and adipocyte-marker induction such as PPARγ and C/EBPα.
-
Collagen-Induced Arthritis
Collagen-induced arthritis (CIA) is an autoimmune murine model of rheumatoid arthritis in which immunization with type II collagen (CII) emulsified in an adjuvant induces a T cell- and autoantibody-driven inflammatory arthritis characterized by synovial hyperplasia, immune cell infiltration, and joint destruction. The model typically relies on genetically susceptible mouse strains (e. g. , DBA/1) and reproduces key features of human rheumatoid arthritis, including anti-collagen immune responses and progressive joint inflammation. Disease onset generally occurs within ~3-4 weeks after immunization, depending on antigen/adjuvant combinations and protocol variation. The immunopathology is driven by adaptive immune activation against CII, leading to systemic and local joint inflammation mediated by pro-inflammatory cytokines and effector immune cells, making CIA a standard preclinical platform for evaluating immunomodulatory and anti-arthritic interventions.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Large-size fat particle sorting
Large-size fat particle sorting is widely used to isolate cells up to 200 μm in diameter. Single-cell flow sorting will allow greater insight into adipocyte heterogeneity by identifying gene expression, protein composition, and metabolic signatures at the single-cell level.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Wang R, et al. Advances in the Pharmacological Activities and Effects of Perilla Ketone and Isoegomaketone. Evid Based Complement Alternat Med. 2022;2022:8809792. Published 2022 Oct 28. [Content Brief]
[2]. Cho BO, et al. Isoegomaketone induces apoptosis through caspase-dependent and caspase-independent pathways in human DLD1 cells. Biosci Biotechnol Biochem. 2011;75(7):1306-1311. [Content Brief]
[3]. Xu S, et al. Isoegomaketone improves radiotherapy efficacy and intestinal injury by regulating apoptosis, autophagy and PI3K/AKT/mTOR signaling in a colon cancer model. Oncol Rep. 2025;53(4):51. [Content Brief]
[4]. Jin CH, et al. Isoegomaketone Alleviates the Development of Collagen Antibody-Induced Arthritis in Male Balb/c Mice. Molecules. 2017;22(7):1209. Published 2017 Jul 19. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)